BPC-157, TB-500, GHK-Cu 70MG (Glow Blend)
Introducing Glow Blend 70MG, a premium research peptide combination featuring BPC-157, TB-500, and GHK-Cu carefully formulated for advanced laboratory and research applications. This powerful blend combines three highly researched compounds known for their potential roles in tissue support, recovery studies, and skin-related research.
Manufactured under strict pharmaceutical-grade standards, Glow Blend is designed to deliver exceptional purity, consistency, and research reliability.
Blend Composition
- BPC-157 – Research peptide commonly studied for recovery and regenerative support
- TB-500 – Synthetic peptide researched for cellular migration and tissue repair
- GHK-Cu – Copper peptide widely researched for skin, hair, and collagen-related studies
Key Features
- Advanced Triple Peptide Formula
- Total Strength: 70MG
- High Purity Research Grade
- Laboratory Tested Quality
- Pharmaceutical-Grade Manufacturing
- Secure Packaging & Reliable Shipping
Potential Research Applications
Glow Blend has gained attention in scientific and laboratory research for studies related to:
- Tissue recovery and repair
- Skin rejuvenation research
- Collagen production support
- Hair and cosmetic peptide studies
- Cellular regeneration research
- Recovery and performance-related studies
Product Specifications
- Product Name: Glow Blend 70MG
- Active Compounds: BPC-157, TB-500, GHK-Cu
- Grade: Pharmaceutical Grade
- Form: Lyophilized Powder
- Purity: High Purity Research Use Only
- Storage: Store in a cool, dry place away from direct sunlight
Important Notice
This product is intended strictly for laboratory research and educational purposes only. It is not intended for human consumption or to diagnose, treat, cure, or prevent any disease.
Why Choose Pharma Grade Peptides?
At Pharma Grade Peptides, we are committed to delivering premium-quality research peptides backed by strict quality control, discreet packaging, secure ordering, and dependable customer support.
Reviews
There are no reviews yet.